COVID-19 / Coronavirus

Astana Club: TOP-10 Risks for Eurasia Are Already Coming True in 2021

2021-02-25 09:00 1890

NUR-SULTAN, Kazakhstan, Feb. 25, 2021 /PRNewswire/ -- Astana Club , one of the most esteemed geopolitical forums for Europe and Asia, announces the latest edition of the international rating "TOP-10 Risks for Eurasia in 2021" ....

MedTech to Take Advantage of Digital Health Platform as a Service Model to Accelerate Digital Transformation across the Healthcare Industry

2021-02-24 20:02 1695

A proven, compliant platform can expedite market entry and optimize time and effort without building competencies internally, finds Frost & Sullivan SANTA CLARA, Calif., Feb. 24, 2021 /PRNewswire/ -- MedTech and Life Sciences companies are transitioning beyondbiopharmaceuticals, medical devices, ...

INOVIO and QIAGEN expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO's VGX-3100 for advanced cervical dysplasia

2021-02-24 14:45 5766

- Liquid biopsy-based precision test guides patient selection and offers potential for cost-effective, non-invasive alternative to surgical removal of cervical lesions - QIAGEN's bioinformatic expertise raises predictive biomarker power in INOVIO's patient selection - First-in-class next genera...

New Research Highlights the Potential of Transforming Healthcare with Mobile EEG Brain Health Assessments

2021-02-24 03:21 1443

Recent publications in Frontiers of Neuroscience, Scientific Report and Neurophysiologie Clinique validate the use of Muse® as a mobile EEG device to measure brain health and performance at scale in real-world environments TORONTO, Feb. 24, 2021 /PRNewswire/ -- In a time with overburdened healthc...

Inovalon Lauded by Frost & Sullivan for Continuously Advancing Data-Driven Healthcare with Its Cloud-Based Inovalon ONE® Platform

2021-02-23 21:00 4699

Inovalon combines industry interconnectivity, large-scale, comprehensive data assets, and analytics with subject matter expertise to support clients strategically SANTA CLARA, Calif., Feb. 23, 2021 /PRNewswire/ -- Based on its recent analysis of the North American healthcare and life sciences an...

RedHill Biopharma Announces Planned Expansion of Opaganib Global Phase 2/3 COVID-19 Study to the U.S.

2021-02-23 20:33 3631

TEL AVIV, Israel and RALEIGH, NC, Feb. 23, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced its plans to expand the Company's global Phase 2/3 study of opaganib[1] ...

New Progress in Study on Mechanism of Lianhua Qingwen Capsules for Treatment of COVID-19

2021-02-23 17:05 2024

SHIJIAZHUANG, China, Feb. 23, 2021 /PRNewswire/ -- Recently, Prof. Caisheng Wu and Prof.Yifeng Chai from the School of Pharmacy, Xiamen University have made new progress in the study of the pharmacologically active ingredients and mechanism of Lianhua Qingwen Capsules, developed and produced by Y...

Surgical Wait Times Technology Now Available in Australia and New Zealand

2021-02-23 05:00 839

Fastest Growing Canadian Health Technology Company Expands Into ANZ SYDNEY, Feb. 23, 2021 /PRNewswire/ -- Wait times in both Australia and New Zealand are too long and how patients are admitted for surgery hasn't changed in decades. Unlike elsewhere, the process is unnecessarily antiquated and ...

Frost & Sullivan Reveals Regional Trends and Cutting-edge Technologies in the Global MRI Market

2021-02-23 00:48 1124

Advanced technologies and applications such as point-of-care, pediatrics, dry-magnets, compact MRI and fusion imaging are driving global market SANTA CLARA, Calif., Feb. 23, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis,Technological Advancements and Emerging Applications in the Global ...

Completion of Patients' Recruitment for Proxalutamide's COVID-19 Hospitalised Study

2021-02-22 17:14 2972

SUZHOU, China, Feb.22, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939) is pleased to announce that the clinical trial of Proxalutamide for the treatment of hospitalised COVID-19 patients inBrazil completed the recruitment of 588 patients. The data of the clinical trial is expected ...

Taming the Black Swan: Multilateral diplomacy for sustainable growth in the era of disruption

2021-02-22 14:20 2588

BANGKOK, Feb. 22, 2021 /PRNewswire/ -- Mr. Don Pramudwinai, Deputy Prime Minister and Minister of Foreign Affairs of the Kingdom of Thailand, and a career diplomat, discussed his vision of the role of diplomacy in Post-Covid 19 sustainability in this opinion piece first published on19 Feb 2021 in...

Frost & Sullivan Shares Strategic Overview of Key Industries and Investment Opportunities in India by 2025

2021-02-19 21:07 4021

Along with industry experts from NITI Aayog and Aditya Birla Group, Frost & Sullivan will discussIndia's economic development and fastest-growing sectors SANTA CLARA, Calif., Feb. 19, 2021 /PRNewswire/ -- From a major economic crisis in 1991,India evolved to become the fastest-growing major econo...

Galderma online survey reveals essential COVID-19 mask wearing can be worsening rosacea skin disease

2021-02-19 14:00 2043

- Although essential for public health, new online survey findings show that people with self-reported rosacea* may be experiencing worsening of symptoms due to mask wearing, further increasing the daily burden for people living with this chronic skin disease - Despite worsening of signs and sym...

BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production

2021-02-18 21:00 5023

SIGNIFICANT ADVANCEMENT TOWARDS LAUNCH OF PHASE I OVARIAN CANCER VACCINE TRIAL VANCOUVER, BC, Feb. 18, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") announced today that it has signed a Term Sheet ("Term Sheet") with BioElpida S.A.S. ...

Seegene's saliva test for COVID-19 is just as effective as NPS test

2021-02-18 11:43 1726

SEOUL, South Korea, Feb.18, 2021 /PRNewswire/ -- A new study shows that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen. A research team at the Department of Laboratory Medicine at Kangwon National University School of Medicine,...

Frost & Sullivan Examines Virtual Critical Care Solutions for Application in the US and EU-5 by 2025

2021-02-18 00:50 1809

Proof of concept set in place by leading solutions providers and flexibility provided by software/web-enabled platforms benefit users of predictive, protocol and surveillance-based solutions SANTA CLARA, Calif., Feb. 18, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that the outb...

New NCCN Guidelines Analyze Evidence for Cancer Type Found Almost Exclusively in Children

2021-02-17 21:35 1594

National Comprehensive Cancer Network publishes first-ever complete medical guidelines for a pediatric solid tumor, so children everywhere receive the best care based on the latest research. NCCN Guidelines for Wilms Tumor shares information for earlier, safer diagnosis and treatment in effort t...

Happiness Biotech Provides Update and Guidance on Sales of Its E-Commerce Business

2021-02-17 21:00 7880

NANPING, China, Feb. 17, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that Happy Buy, the Company's wholly-owned subsidiary focusing on e-commerce business, recorded s...

RedHill Biopharma Announces First Patient Dosed in U.S. Phase 2/3 COVID-19 Outpatient Study with RHB-107

2021-02-17 20:00 3305

- The U.S. Phase 2/3 study with once-daily, orally-administered RHB-107 (upamostat) evaluates treatment of patients with symptomatic COVID-19 who do not require hospitalization - the vast majority of patients - RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in...

Launch of ESMO Virtual Plenaries Brings Rapid Access to Ground-Breaking Cancer Research

2021-02-17 13:00 1384

Timely presentations of trial data will accelerate transition from research to practice LUGANO, Switzerland, Feb. 17, 2021 /PRNewswire/ -- ESMO, the leading organisation for medical oncology, launches an important new service for rapidly disseminating research to accelerate the transition of res...

1 ... 107108109110111112113 ... 225

Week's Top Stories